Teva referred virtually all Copaxone patients who faced Medicare co-pays to ACS, which liaised with the foundations to calculate how much money was needed to cover the co-payments.

Shares in Teva were down sharply this week after the US Department of Justice filed a complaint that the company paid illegal kickbacks to patient groups to boost sales of its multiple sclerosis ...